OnCore CTMS vs. Salesforce Life Sciences Cloud
A side-by-side comparison based on G2 review data.
| Metric | OnCore CTMS | Salesforce Life Sciences Cloud |
|---|---|---|
| Overall rating | 4.4 | 4.1 |
| Review count | 14 | 39 |
| Ease of use | 8.3 | 8.5 |
| Ease of setup | 7.8 | 8.3 |
| Quality of support | 9.0 | 0.0 |
| Meets requirements | 9.0 | 7.1 |
| NPS | 57.142857 | 25.714286 |
| Small Business | 14.3% | 20.5% |
| Mid-Market | 28.6% | 38.5% |
| Enterprise | 57.1% | 41.0% |
| Total page views | 130 | 382 |
| Total LLM citations | 288 | 484 |
OnCore CTMS
OnCore CTMS is the trusted clinical trial management system (CTMS) used by nearly 90% of NCI-designated cancer centers and more than 90 of the top 125 academic medical centers. It streamlines operational, financial, and regulatory workflows to improve efficiency and quality across the research lifecycle. OnCore supports research sites and institutions with strong financial compliance through integrations with billing systems that enable end-to-end financial management. Deep EMR integrations provide seamless connectivity with widely used institutional systems.
Salesforce Life Sciences Cloud
Salesforce Life Sciences Cloud is an intelligent, AI-first end-to-end engagement platform that redefines how the clinical, medical, and commercial teams engage with patients, healthcare providers, clinical trial sites and care ecosystems to bring new therapies to market faster. Built on the deeply unified Platform, it enables pharma and medtech organizations to personalize customer interactions, streamline clinical operations, and improve patient outcomes with data, contextual insights, and trusted AI.